Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox’s Completes Pre-Defined Enrollment of NCX 4251 Mississippi Phase 2b Blepharitis Trial

June 1, 2021

View Press Release Corporate presentation Contact us
Previous